Sildenafil Tablet, Film Coated
Product Images NDC 82804-243

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 82804-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 02)

Chemical structure of Sildenafil displayed as a two-dimensional molecular diagram, showing detailed atomic connections including rings, functional groups, and side chains.*

FDA Label Image

4 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 05)

A line graph showing change from baseline in meters over 12 weeks of study, comparing placebo and three Sildenafil doses (20 mg TID, 40 mg TID, 80 mg TID). Data points indicate increasing improvement with higher Sildenafil doses over time, with error bars displayed at each time point (weeks 4, 8, and 12). The x-axis represents the week of study, and the y-axis indicates the change from baseline in meters.*

FDA Label Image

5 (55aa9711 6df5 4516 Bf00 A1acf7f7a464 06)

A forest plot chart illustrating placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various patient subgroups. Subgroups include baseline walk distance, etiology, pulmonary hypertension classification, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance index. The chart shows number of subjects and effect estimates with confidence intervals for each subgroup.*

FDA Label Image

Pi Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 09)

FDA Label Image

Logo (55aa9711 6df5 4516 Bf00 A1acf7f7a464 10)

FDA Label Image

Figure-1 (Figure 1)

A forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic variables (AUC and Cmax) of sildenafil when coadministered with various interacting drugs. The plot includes drugs like Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, with recommendations on dose adjustment ranging from 'No dose adjustment' to 'Coadministration not recommended.'*

FDA Label Image

Figure-2 (Figure 2)

A chart showing fold change and 90% confidence intervals for various interacting drugs with sildenafil, comparing pharmacokinetic parameters such as INR, AUC, and Cmax relative to the interacting drug alone. Recommendations for dose adjustments or coadministration for each interacting drug are listed, including no dose adjustment or cautionary notes against coadministration for certain drugs like bosentan and ritonavir.*

FDA Label Image

Figure-5 (Figure 5)

A line graph comparing the percentage of subjects without a clinically worsening event over time between Sildenafil and Placebo groups. The x-axis represents days from randomization, and the y-axis shows the percentage without event, with Sildenafil showing a higher percentage over the 112-day period.*

FDA Label Image

82804-243-30 (Image 01)

Label for Sildenafil 20 mg film-coated oral tablets by Proficient Rx LP. The label includes a quantity of 30 tablets, stating each contains sildenafil citrate USP equivalent to 20 mg sildenafil. Manufacturer listed as Torrent Pharmaceuticals Ltd., India. The tablets are described as white to off-white, round biconvex, debossed with '85' on one side. Storage and safety instructions are also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.